Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$8.3 million.

  • Lifecore Biomedical, Inc. \De\'s Enterprise Value rose 232.81% to -$8.3 million in Q2 2025 from the same period last year, while for May 2025 it was -$8.3 million, marking a year-over-year increase of 232.81%. This contributed to the annual value of -$8.3 million for FY2025, which is 232.81% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Enterprise Value amounted to -$8.3 million in Q2 2025, which was up 232.81% from -$5.4 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Enterprise Value ranged from a high of -$609000.0 in Q4 2021 and a low of -$19.1 million during Q2 2023
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Enterprise Value had a median value of -$2.7 million in 2022 and averaged -$4.9 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Enterprise Value soared by 7540.39% in 2021 and then tumbled by 182643.79% in 2023.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Enterprise Value stood at -$609000.0 in 2021, then tumbled by 875.04% to -$5.9 million in 2022, then plummeted by 221.51% to -$19.1 million in 2023, then skyrocketed by 50.47% to -$9.5 million in 2024, then rose by 12.59% to -$8.3 million in 2025.
  • Its Enterprise Value was -$8.3 million in Q2 2025, compared to -$5.4 million in Q1 2025 and -$9.5 million in Q4 2024.